Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins

Tumor targeting is a booming business: The global therapeutic monoclonal antibody market accounted for more than $78 billion in 2012 and is expanding exponentially. Tumors can be targeted with an extensive arsenal of monoclonal antibodies, ligand proteins, peptides, RNAs, and small molecules. In add...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonstra, Martin C., de Geus, Susanna W.L., Prevoo, Hendrica A.J.M., Hawinkels, Lukas J.A.C., van de Velde, Cornelis J.H., Kuppen, Peter J.K., Vahrmeijer, Alexander L., Sier, Cornelis F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040425/
https://www.ncbi.nlm.nih.gov/pubmed/27721658
http://dx.doi.org/10.4137/BIC.S38542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040425/
https://www.ncbi.nlm.nih.gov/pubmed/27721658
http://dx.doi.org/10.4137/BIC.S38542

Ejemplares similares